Skip to main content
Grafa
Technology
908 Devices revenue surpasses $16 million with 23% increase
Image for illustrative purposes only. Not a real photo.

908 Devices revenue surpasses $16 million with 23% increase

Share
  • 908 Devices reported Q2 2026 revenue of $16.1 million, up 23% year over year, while recurring revenue reached $4.9 million.
  • MASS shares were up about 4.2% at $9.17 in regular Nasdaq trading following the results.
  • 908 Devices raised the low end of its 2026 revenue guidance to $68–$70 million from $67–$70 million.

908 Devices (NASDAQ:MASS) reported second-quarter 2026 revenue of $16.1 million, up 23% year over year, as VipIR and NIRLab sales supported growth.

Gross margin improved to 52% from 49%, while adjusted gross margin reached 57% and recurring revenue represented 31% of quarterly sales.

Net loss from continuing operations narrowed to $11.9 million, adjusted EBITDA loss improved to $1.9 million and cash totaled $101.5 million.

908 Devices also raised 2026 revenue guidance to $68–$70 million.

The company acquired NIRLAB SA during Q2 for $13.5 million of cash and said it engaged hundreds of U.S. prospects across more than 30 agencies within 60 days.

908 Devices also surpassed 100 cumulative VipIR shipments and secured a $6 million ProtectIR order from an Asia-Pacific corrections agency after quarter-end.